Iomabb Actinium Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iomabb actinium pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iomabb Actinium Pharmaceuticals Today - Breaking & Trending Today

Iomab-B may increase transplant access, improve outcomes in relapsed/refractory AML

Targeted conditioning with iodine (131I) apamistamab enabled older patients with relapsed or refractory acute myeloid leukemia to undergo allogeneic hematopoietic stem cell transplantation, according to results of the phase 3 SIERRA trial.The findings, presented at 2023 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, showed iodine (131I) apamistamab, known ....

Mindy Valcarcel , Sergioa Giralt , Miltenyi Biotec , Bydevin Mclaughlin , Jazz Pharmaceuticals , Spectrum Pharmaceuticals , Weill Cornell Medical College , Bristol Myers Squibb , Fred Hutchinson Cancer Research Center , Iomabb Actinium Pharmaceuticals , Memorial Sloan Kettering Cancer Center , Actinium Pharmaceuticals , Tandem Meetings , Cellular Therapy Meetings , Kite Pharma , Melvin Berlin , Hemonc Today Editorial Board Member ,